New Medicine Guidance from the CSP

New Medicine Guidance from the CSP

The use of medicines in physiotherapy injection-therapy settings has been commonplace for many years. More recently, with the introduction of prescribing rights for physiotherapists, the mechanisms by which physiotherapists can access medicines have increased. In addition, the increasing provision of physiotherapy services by independent providers of healthcare has required a greater understanding of medicines frameworks in non-NHS settings.

In recent years, the issue of "mixing‟ of medicines has become a matter of intense professional debate, resulting in clarification of the law and substantive guidance on the matter from a range of national organisations, including the introduction of CSP Information Paper PD003, of which several versions have been published to keep pace with changing clinical practice.

This 4th edition includes an updated legislative framework to reflect, firstly, the introduction of The Human Medicines Regulations in 2012 and, secondly, the planned introduction of independent prescribing by physiotherapists. This new edition also aims to provide one common resource which physiotherapists using injection therapy in any sector can reference for general information.

Please note that previous editions of this publication have had different titles: "The use of medicines in physiotherapy injection-therapy in NHS settings" and "Mixing of medicines in physiotherapy practice".


Leave a Reply